Log In
Sunday 18th March 2018

GSK's new chief executive ditches over 30 drug research projects in strategic review

26th July 2017

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018